However, the specificity of AE007 for RSK2 was not evaluated and it is unknown whether the decreased in vitro proliferation and in vivo tumor growth in melanoma models was due to RSK2 inhibition (Supplementary Table S3). This evidence concerns the gene RPS6KA3 and neoplasm.